BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12670496)

  • 21. Urban dust particulate matter alters PAH-induced carcinogenesis by inhibition of CYP1A1 and CYP1B1.
    Courter LA; Musafia-Jeknic T; Fischer K; Bildfell R; Giovanini J; Pereira C; Baird WM
    Toxicol Sci; 2007 Jan; 95(1):63-73. PubMed ID: 17060372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
    Chang TK; Chen J; Yang G; Yeung EY
    J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CYP1A1 and CYP3A4 modulation by dietary flavonoids in human intestinal Caco-2 cells.
    Sergent T; Dupont I; Van der Heiden E; Scippo ML; Pussemier L; Larondelle Y; Schneider YJ
    Toxicol Lett; 2009 Dec; 191(2-3):216-22. PubMed ID: 19766177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009.
    Shimada T; Oda Y; Gillam EM; Guengerich FP; Inoue K
    Drug Metab Dispos; 2001 Sep; 29(9):1176-82. PubMed ID: 11502724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heteroactivation of cytochrome P450 1A1 by teas and tea polyphenols.
    Anger DL; Petre MA; Crankshaw DJ
    Br J Pharmacol; 2005 Aug; 145(7):926-33. PubMed ID: 15895106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.
    Chang TK; Chen J; Lee WB
    J Pharmacol Exp Ther; 2001 Dec; 299(3):874-82. PubMed ID: 11714871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent inhibition of human cytochrome P450 1 enzymes by dimethoxyphenylvinyl thiophene.
    Lee SK; Kim Y; Kim MY; Kim S; Chun YJ
    Arch Pharm Res; 2004 Feb; 27(2):199-205. PubMed ID: 15022723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potent inhibition of human cytochrome P450 1B1 by tetramethoxystilbene.
    Chun YJ; Oh YK; Kim BJ; Kim D; Kim SS; Choi HK; Kim MY
    Toxicol Lett; 2009 Aug; 189(1):84-9. PubMed ID: 19463925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bifunctional modulating effects of an indigo dimer (bisindigotin) to CYP1A1 induction in H4IIE cells.
    Lai KP; Mak NK; Wei X; Wong RN; Wong MH; Wong CK
    Toxicology; 2006 Sep; 226(2-3):188-96. PubMed ID: 16901605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A methoxyflavonoid, chrysoeriol, selectively inhibits the formation of a carcinogenic estrogen metabolite in MCF-7 breast cancer cells.
    Takemura H; Uchiyama H; Ohura T; Sakakibara H; Kuruto R; Amagai T; Shimoi K
    J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):70-6. PubMed ID: 19833205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of human recombinant cytochromes P450 CYP1A1 and CYP1B1 by trans-resveratrol methyl ethers.
    Mikstacka R; Przybylska D; Rimando AM; Baer-Dubowska W
    Mol Nutr Food Res; 2007 May; 51(5):517-24. PubMed ID: 17440990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effect of phenethyl isothiocyanate against benzo[a] pyrene-induced rise in CYP1A1 mRNA and apoprotein levels as its chemopreventive properties.
    Abdull Razis AF; Konsue N; Ioannides C
    Asian Pac J Cancer Prev; 2015; 16(7):2679-83. PubMed ID: 25854346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral administration of naturally occurring coumarins leads to altered phase I and II enzyme activities and reduced DNA adduct formation by polycyclic aromatic hydrocarbons in various tissues of SENCAR mice.
    Kleiner HE; Vulimiri SV; Miller L; Johnson WH; Whitman CP; DiGiovanni J
    Carcinogenesis; 2001 Jan; 22(1):73-82. PubMed ID: 11159744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary polyphenols protect against N-nitrosamines and benzo(a)pyrene-induced DNA damage (strand breaks and oxidized purines/pyrimidines) in HepG2 human hepatoma cells.
    Delgado ME; Haza AI; Arranz N; García A; Morales P
    Eur J Nutr; 2008 Dec; 47(8):479-90. PubMed ID: 18974940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of carcinogen-activating enzymes by 16alpha-fluoro-5-androsten-17-one.
    Ciolino HP; MacDonald CJ; Yeh GC
    Cancer Res; 2002 Jul; 62(13):3685-90. PubMed ID: 12097275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidation of carcinogenic benzo[a]pyrene by human and rat cytochrome P450 1A1 and its influencing by cytochrome b5 - a comparative study.
    Indra R; Moserova M; Sulc M; Frei E; Stiborova M
    Neuro Endocrinol Lett; 2013; 34 Suppl 2():55-63. PubMed ID: 24362093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene.
    Revel A; Raanani H; Younglai E; Xu J; Rogers I; Han R; Savouret JF; Casper RF
    J Appl Toxicol; 2003; 23(4):255-61. PubMed ID: 12884409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.
    Androutsopoulos VP; Papakyriakou A; Vourloumis D; Spandidos DA
    Bioorg Med Chem; 2011 May; 19(9):2842-9. PubMed ID: 21482471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Butyrate alters expression of cytochrome P450 1A1 and metabolism of benzo[a]pyrene via its histone deacetylase activity in colon epithelial cell models.
    Zapletal O; Tylichová Z; Neča J; Kohoutek J; Machala M; Milcová A; Pokorná M; Topinka J; Moyer MP; Hofmanová J; Kozubík A; Vondráček J
    Arch Toxicol; 2017 May; 91(5):2135-2150. PubMed ID: 27830268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigallocatechin-3-gallate does not affect the activity of enzymes involved in metabolic activation and cellular excretion of benzo[a]pyrene in human colon carcinoma cells.
    Bothe H; Gassmann K; Götz C; Fritsche E; Abel J; Haarmann-Stemmann T
    Toxicol Lett; 2011 Jun; 203(3):258-64. PubMed ID: 21458546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.